- Home
- TARA vs JRVR Comparison
TARA vs JRVR Comparison
Compare TARA & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARA | JRVR |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 209.9M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TARA | JRVR |
|---|---|---|
| Price | $3.84 | $4.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $24.40 | $7.33 |
| AVG Volume (30 Days) | ★ 367.3K | 241.1K |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | 38.25 | ★ 125.82 |
| EPS | N/A | ★ N/A |
| Revenue | $2,948,000.00 | ★ $687,614,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.02 | $3.76 |
| 52 Week High | $7.82 | $7.20 |
Technical Indicators
Market Signals| Indicator | TARA | JRVR |
|---|---|---|
| Relative Strength Index (RSI) | 39.68 | 36.75 |
| Support Level | $3.73 | $3.82 |
| Resistance Level | $4.20 | $4.36 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 15.19 | 17.48 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.